Crossmark

Efficacy of 4 Weeks Therapy with Eplerenone in Resistant Hypertension: Reduction of Aortic Blood Pressure, Arterial Stiffness, and Impact on IL-6 Levels

Crossref DOI link: https://doi.org/10.1007/s44200-025-00095-7

Published Online: 2025-11-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wasiliew, Stanisław

Lipski, Dawid

Stryczyński, Łukasz

Radziemski, Artur

Królak, Jan

Tykarski, Andrzej

Uruski, Paweł
License Information

Text and Data Mining valid from 2025-11-28

Version of Record valid from 2025-11-28
More Information

Article History

Received: 5 August 2025

Accepted: 18 November 2025

First Online: 28 November 2025

Declarations

:

: The authors declare no competing interests.

: The study was approved by the Bioethics Committee at the Karol Marcinkowski University of Medical Sciences in Poznań. Approval number 775/15.

: In accordance with the study protocol, all participants provided written informed consent. Signed consent forms are available from the corresponding author.

: All authors consent to the publication of this manuscript in Artery Research .

Document is current

Any future updates will be listed below